Results 191 to 200 of about 115,328 (341)

Comparative efficacy and safety of teriparatide versus bisphosphonates in osteoporosis: a meta-analysis. [PDF]

open access: yesFront Surg
Jin H   +9 more
europepmc   +1 more source

Periodontal Disease as a Risk Factor for Bisphosphonate‐Related Osteonecrosis of the Jaw

open access: green, 2013
Vivek Thumbigere‐Math   +6 more
openalex   +2 more sources

Orthodontic treatment in periodontitis patients

open access: yesPeriodontology 2000, EarlyView.
Abstract This paper examines the complex interplay between orthodontic intervention and periodontal conditions in individuals with periodontitis. It outlines diagnostic and treatment approaches for adolescents and adults, considering their distinct periodontal, dental, and behavioral needs.
Tali Chackartchi   +3 more
wiley   +1 more source

Bisphosphonates as a Tacrolimus-Sparing Strategy in Kidney Transplantation: Insights from a Retrospective Analysis. [PDF]

open access: yesYonsei Med J
Koh HB   +12 more
europepmc   +1 more source

Emerging locally delivered antimicrobial and immunomodulatory approaches for the prevention/treatment of peri‐implant diseases

open access: yesPeriodontology 2000, EarlyView.
Abstract Peri‐implant diseases are dysbiosis‐mediated inflammatory disorders that occur in susceptible hosts. Antimicrobials and immunomodulatory agents therefore might be pertinent as adjunctive measures in the treatment of such disorders. The aim of this narrative review was to examine the existing evidence and assess the effectiveness of emerging ...
Alberto Monje   +3 more
wiley   +1 more source

Revision Distal Bicep Repair in the Setting of Heterotopic Ossification: Case Study

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
Radiographic and intraoperative findings demonstrating heterotopic ossification following distal biceps tendon repair. ABSTRACT Heterotopic ossification (HO) following distal biceps tendon repair is an uncommon but potential complication. This may present pain, limited range of motion, or sensory changes due to nerve compression.
Aidan M. Brikho   +2 more
wiley   +1 more source

Anti‐Her2 therapy patterns in metastatic breast cancer—Real‐world data suggest undertreatment

open access: yesInternational Journal of Cancer, Volume 158, Issue 3, Page 633-641, 1 February 2026.
What's new? Although human epidermal growth factor 2‐positive (HER2+) breast cancer is an aggressive malignancy, significant survival benefits are possible with targeted anti‐HER2 therapies. Whether these therapies are used as recommended, however, is unknown. Here, the authors investigated data from population‐based registries in Norway to assess anti‐
Kathrine F. Vandraas   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy